The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

NCT01224509 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Longer than expected recruitment period.

Conditions

Cervical Prostaglandin EP3 Receptors
Pregnancy

Interventions

DRUG: Mifepristone
OTHER: Non-treatment

Sponsor

University of Southern California